LPS response pattern of inflammatory adipokines in an in vitro 3T3-L1 murine adipocyte model

Inflammation Research

Volumn 63, Issue 6, 2014, Pages 495-507

  Chirumbolo, Salvatore ^a   Franceschetti, Guido ^a   Zoico, Elena ^a   Bambace, Clara ^a   Cominacini, Luciano ^a   Zamboni, Mauro ^a  

^a UNIVERSITY OF VERONA   (Italy)

Author keywords

Adipocyte; Adipokine; CXCL12 SDF1 ; Inflammation; Lipopolysaccharide; MIP 1 CCL3

Indexed keywords

ADIPOCYTOKINE; INTERLEUKIN 10; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MESSENGER RNA; STROMAL CELL DERIVED FACTOR 1; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE;

3T3 CELL LINE; ADIPOCYTE; ANIMAL CELL; ARTICLE; CELL ACTIVATION; CELL CULTURE; CELL VIABILITY; CYTOKINE PRODUCTION; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; GENETIC TRANSCRIPTION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; ANIMAL; CELL SURVIVAL; DRUG EFFECTS; GENETICS; IMMUNOLOGY;

3T3-L1 CELLS; ADIPOCYTES; ADIPOKINES; ANIMALS; CELL SURVIVAL; CYTOKINES; GENE EXPRESSION; LIPOPOLYSACCHARIDES; MICE;

EID: 84901288662     PISSN: 10233830     EISSN: 1420908X     Source Type: Journal    
DOI: 10.1007/s00011-014-0721-9     Document Type: Article

References (65)

1. Shi H, Kokoeva MV, Inouye K, Tzameli I, Yin H, Flier JS. TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest. 2006;116:3015-25. (Pubitemid 44684486)
2. Harte AL, da Silva NF, Creely SJ, McGee KC, Billyard T, Youssef-Elabd EM, Tripathi G, Ashour E, Abdalla MS, Sharada HM, Amin AI, Burt AD, Kumar S, Day CP, McTernan PG. Elevated endotoxin levels in non-alcoholic fatty liver disease. J Inflamm (Lond). 2010;7:15.
3. Leuwer M, Welters I, Marx G, Rushton A, Bao H, Hunter L, Trayhurn P. Endotoxaemia leads to major increases in inflammatory adipokine gene expression in white adipose tissue of mice. Pflugers Arch. 2009;457(4):731-41.
4. Rosen ED, Walkey CJ, Puigserver P, Spiegelman BM. Transcriptional regulation of adipogenesis. Genes Dev. 2000;14:1293-307. (Pubitemid 30397073)
5. Mandrup S, Lane MD. Regulating adipogenesis. J Biol Chem. 1997;272:5367-70. (Pubitemid 27102351)
6. Kennedy A, Gruen ML, Gutierrez DA, Surmi BK, Orr JS, Webb CD, Hasty AH. Impact of macrophage inflammatory protein-1α deficiency on atherosclerotic lesion formation, hepatic steatosis, and adipose tissue expansion. PLoS One. 2012;7(2):e31508.
7. Ognjanovic S, Jacobs DR, Steinberger J, Moran A, Sinaiko AR. Relation of chemokines to BMI and insulin resistance at ages 18-21. Int J Obes (Lond). 2013;37(3):420-3.
8. Samaras K, Botelho NK, Chisholm DJ, Lord RV. Subcutaneous and visceral adipose tissue gene expression of serum adipokines that predict type 2 diabetes. Obesity (Silver Spring). 2010;18(5):884-9.
9. Wang Y, Huang J, Li Y, Yang GY. Roles of chemokine CXCL12 and its receptors in ischemic stroke. Curr Drug Targets. 2012;13(2):166-72.
10. Murdoch C, Monk PN, Finn A. CXC chemokine receptor expression on human endothelial cells. Cytokine. 1999;9:704-12. (Pubitemid 29428004)
11. Lee YH, Nair S, Rousseau E, Allison DB, Page GP, Tataranni PA, Bogardus C, Permana PA. Microarray profiling of isolated abdominal subcutaneous adipocytes from obese vs. nonobese Pima Indians: increased expression of inflammation-related genes. Diabetologia. 2005;48(9):1776-83. (Pubitemid 41317831)
12. Meijer K, de Vries M, Al-Lahham S, Bruinenberg M, Weening D, Dijkstra M, Kloosterhuis N, van der Leij RJ, van der Want H, Kroesen BJ, Vonk R, Rezaee F. Human primary adipocytes exhibit immune cell function: adipocytes prime inflammation independent of macrophages. PLoS One. 2011;6(3):e17154.
13. Mehta NN, Li M, William D, Khera AV, DerOhannessian S, Qu L, Ferguson JF, McLaughlin C, Shaikh LH, Shah R, Patel PN, Bradfield JP, He J, Stylianou IM, Hakonarson H, Rader DJ, Reilly MP. The novel atherosclerosis locus at 10q11 regulates plasma CXCL12 levels. Eur Heart J. 2011;32(8):963-71.
14. Wu H, Ghosh S, Perrard XD, Feng L, Garcia GE, Perrard JL, Sweeney JF, Peterson LE, Cha L, Smith CW, Ballantyne CM. T-cell accumulation and regulated on activation, normal T cell expressed and secreted up-regulation in adipose tissue in obesity. Circulation. 2007;115:1029-38. (Pubitemid 46328297)
15. Kintscher U, Hartge M, Hess K, Foryst-Ludwig A, Clemenz M, Wabitsch M, Fischer-Posovszky P, Barth TF, Dragun D, Skurk T, Hauner H, Bluher M, Unger T, Wolf AM, Knippschild U, Hombach V, Marx N. T-lymphocyte infiltration in visceral adipose tissue: a primary event in adipose tissue inflammation and the development of obesity-mediated insulin resistance. Arterioscler Thromb Vasc Biol. 2008;28:1304-10.
16. Kosacka J, Gericke M, Nowicki M, Kacza J, Borlak J, Spanel-Borowski K. Apolipoproteins D and E3 exert neurotrophic and synaptogenic effects in dorsal root ganglion cell cultures. Neuroscience. 2009;162(2):282-91.
17. Kremer KN, Kumar A, Hedin KE. Haplotype-independent costimulation of IL-10 secretion by SDF-1/CXCL12 proceeds via AP-1 binding to the human IL-10 promoter. J Immunol. 2007;178(3):1581-8. (Pubitemid 46154629)
18. Lira FS, Rosa JC, Pimentel GD, Seelaender M, Damaso AR, Damaso AR, Oyama LM, do Nascimento CO. Both adiponectin and interleukin-10 inhibit LPS-induced activation of the NF-κB pathway in 3T3-L1 adipocytes. Cytokine. 2012;57(1):98-106.
19. Turner JJ, Foxwell KM, Kanji R, Brenner C, Wood S, Foxwell BM, Feldmann M. Investigation of nuclear factor-κB inhibitors and interleukin-10 as regulators of inflammatory signalling in human adipocytes. Clin Exp Immunol. 2010;162(3):487-93.
20. Yuan G, Jia J, Di L, Zhou L, Dong S, Ye J, Wang D, Yang L, Wang J, Li L, Yang Y, Mao C, Chen M. Effects of C-reactive protein on adipokines genes expression in 3T3-L1 adipocytes. Biochem Biophys Res Commun. 2012;424(3):462-8.
21. Wang B, Trayhurn P. Acute and prolonged effects of TNF-alpha on the expression and secretion of inflammation-related adipokines by human adipocytes differentiated in culture. Pflugers Arch. 2006;452(4):418-27. (Pubitemid 43962051)
22. Wang Y, Huang J, Li Y, Yang GY. Roles of chemokine CXCL12 and its receptors in ischemic stroke. Curr Drug Targets. 2012;13(2):166-72.
23. Farouk SS, Rader DJ, Reilly MP, Mehta NN. CXCL12: a new player in coronary disease identified through human genetics. Trends Cardiovasc Med. 2010;20(6):204-9.
24. Fernyhough ME, Okine E, Hausman G, Vierck JL, Dodson MV. PPARgamma and GLUT-4 expression as developmental regulators/markers for preadipocyte differentiation into an adipocyte. Domest Anim Endocrinol. 2007;33(4):367-78. (Pubitemid 47513814)
25. Wilhelm J, Pingoud A. Real-time polymerase chain reaction. Chembiochem. 2003;4(11):1120-8. (Pubitemid 37462812)
26. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25(4):402-8. (Pubitemid 34164012)
27. Yamashita A, Soga Y, Iwamoto Y, Asano T, Li Y, Abiko Y, Nishimura F. DNA microarray analyses of genes expressed differentially in 3T3-L1 adipocytes co-cultured with murine macrophage cell line RAW264.7 in the presence of the toll-like receptor 4 ligand bacterial endotoxin. Int J Obes (Lond). 2008;32(11):1725-9.
28. Lin Y, Lee H, Berg AH, Lisanti MP, Shapiro L, Scherer PE. The lipopolysaccharide activated toll-like receptor (TLR)-4 induces synthesis of the closely related receptor TLR2 in adipocytes. J Biol Chem. 2000;275:24255-63. (Pubitemid 30626513)
29. Ajuwon KM, Banz W, Winters TA. Stimulation with Peptidoglycan induces interleukin 6 and TLR2 expression and a concomitant downregulation of expression of adiponectin receptors 1 and 2 in 3T3-L1 adipocytes. J Inflamm (Lond). 2009;6:8.
30. Zoico E, Di Francesco V, Olioso D, Fratta Pasini AM, Sepe A, Bosello O, Cinti S, Cominacini L, Zamboni M. In vitro aging of 3T3-L1 mouse adipocytes leads to altered metabolism and response to inflammation. Biogerontology. 2010;11(1):111-22.
31. Hoch M, Eberle AN, Peterli R, Peters T, Seboek D, Keller U, Muller B, Linscheid P. LPS induces interleukin-6 and interleukin-8 but not tumor necrosis factor-alpha in human adipocytes. Cytokine. 2008;41(1):29-37. (Pubitemid 350309715)
32. Hoareau L, Ravanan P, Gonthier MP, Delarue P, Gonçalves J, Césari M, Festy F, Roche R. Effect of PEA on LPS inflammatory action in human adipocytes. Cytokine. 2006;34(5-6):291-6.
33. Pedersen BK, Steensberg A, Fischer C, Keller C, Keller P, Plomgaard P, Wolsk-Petersen E, Febbraio M. The metabolic role of IL-6 produced during exercise: is IL-6 an exercise factor? Proc Nutr Soc. 2004;63(2):263-7. (Pubitemid 38787476)
34. Chazenbalk G, Bertolotto C, Heneidi S, Jumabay M, Trivax B, Aronowitz J, Yoshimura K, Simmons CF, Dumesic DA, Azziz R. Novel pathway of adipogenesis through cross-talk between adipose tissue macrophages, adipose stem cells and adipocytes: evidence of cell plasticity. PLoS One. 2011;6(3):e17834.
35. Zu L, He J, Jiang H, Xu C, Pu S, Xu G. Bacterial endotoxin stimulates adipose lipolysis via toll-like receptor 4 and extracellular signal-regulated kinase pathway. J Biol Chem. 2009;284(9):5915-26.
36. Huang S, Rutkowsky JM, Snodgrass RG, Ono-Moore KD, Schneider DA, Newman JW, Adams SH, Hwang DH. Saturated fatty acids activate TLR-mediated pro-inflammatory signaling pathways. J Lipid Res. 2012;53(9):2002-13.
37. Ji C, Chen X, Gao C, Jiao L, Wang J, Xu G, Fu H, Guo X, Zhao Y. IL-6 induces lipolysis and mitochondrial dysfunction, but does not affect insulin-mediated glucose transport in 3T3-L1 adipocytes. J Bioenerg Biomembr. 2011;43(4):367-75.
38. Bosmann M, Russkamp NF, Ward PA. Fingerprinting of the TLR4-induced acute inflammatory response. Exp Mol Pathol. 2012;93(3):319-23.
39. Altemeier WA, Matute-Bello G, Gharib SA, Glenny RW, Martin TR, Liles WC. Modulation of lipopolysaccharide-induced gene transcription and promotion of lung injury by mechanical ventilation. J Immunol. 2005;175(5):3369-76. (Pubitemid 41170559)
40. Hammer M, Mages J, Dietrich H, Servatius A, Howells N, Cato AC, Lang R. Dual specificity phosphatase 1 (DUSP1) regulates a subset of LPS-induced genes and protects mice from lethal endotoxin shock. J Exp Med. 2006;203(1):15-20. (Pubitemid 43139639)
41. Buxadé M, Lunazzi G, Minguillón J, Iborra S, Berga-Bolaños R, Del Val M, Aramburu J, López-Rodríguez C. Gene expression induced by Toll-like receptors in macrophages requires the transcription factor NFAT5. J Exp Med. 2012;209(2):379-93.
42. Dolinková M, Dostálová I, Lacinová Z, Michalský D, Haluzíková D, Mráz M, Kasalický M, Haluzík M. The endocrine profile of subcutaneous and visceral adipose tissue of obese patients. Mol Cell Endocrinol. 2008;291(1-2):63-70.
43. Hursting SD, Hursting MJ. Growth signals, inflammation, and vascular perturbations: mechanistic links between obesity, metabolic syndrome, and cancer. Arterioscler Thromb Vasc Biol. 2012;32(8):1766-70.
44. Romeo GR, Lee J, Shoelson SE. Metabolic syndrome, insulin resistance, and roles of inflammation-mechanisms and therapeutic targets. Arterioscler Thromb Vasc Biol. 2012;32(8):1771-6.
45. Ouchi N, Ohashi K, Shibata R, Murohara T. Adipocytokines and obesity-linked disorders. Nagoya J Med Sci. 2012;74(1-2):19-30.
46. Mantovani A, Sica A, Sozzani S, Allavena P, Vecchi A, Locati M. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. 2004;25:677-86. (Pubitemid 39457982)
47. Gerhardt CC, Romero IA, Cancello R, Camoin L, Strosberg AD. Chemokines control fat accumulation and leptin secretion by cultured human adipocytes. Mol Cell Endocrinol. 2001;175(1-2):81-92. (Pubitemid 32372545)
48. Hazan U, Romero IA, Cancello R, Valente S, Perrin V, Mariot V, Dumonceaux J, Gerhardt CC, Strosberg AD, Couraud PO, Pietri-Rouxel F. Human adipose cells express CD4, CXCR4, and CCR5 [corrected] receptors: a new target cell type for the immunodeficiency virus-1? FASEB J. 2002;16(10):1254-6.
49. Moon H, Lee JG, Shin SH, Kim TJ. LPS-induced migration of peritoneal B-1 cells is associated with upregulation of CXCR4 and increased migratory sensitivity to CXCL12. J Korean Med Sci. 2012;27(1):27-35.
50. Bonavia R, Bajetto A, Barbero S, Pirani P, Florio T, Schettini G. Chemokines and their receptors in the CNS: expression of CXCL12/SDF-1 and CXCR4 and their role in astrocyte proliferation. Toxicol Lett. 2003;139(2-3):181-9. (Pubitemid 36298976)
51. Kennedy, R.L., Thomas, L., Garland, S., and Kazi, M. CXCL12 (stromal cell derived factorsecretion by preadipocytes is enhanced by short-chain fatty acids acting through a G protein-coupled receptor (GPR41). Papers from ESA Annual Scientific Meeting 2007. ESA Annual Scientific Meeting 2007, 2-5 September 2007, Christchurch, New Zealand.
52. Morandini AC. Chaves Souza PP, Ramos-Junior ES, Souza Costa CA, Santos CF. MyD88 or TRAM knockdown regulates interleukin (IL)-6, IL-8, and CXCL12 mRNA expression in human gingival and periodontal ligament fibroblasts. J Periodontol. 2013;84(9):1353-60.
53. Foryst-Ludwig A, Hartge M, Clemenz M, Sprang C, Hess K, Marx N, Unger T, Kintscher U. PPARgamma activation attenuates T-lymphocyte-dependent inflammation of adipose tissue and development of insulin resistance in obese mice. Cardiovasc Diabetol. 2010;18(9):64.
54. Chanteux H, Guisset AC, Pilette C, Sibille Y. LPS induces IL-10 production by human alveolar macrophages via MAPKinases- and Sp1-dependent mechanisms. Respir Res. 2007;4(8):71.
55. Berg DJ, Kühn R, Rajewsky K, Müller W, Menon S, Davidson N, Grünig G, Rennick D. Interleukin-10 is a central regulator of the response to LPS in murine models of endotoxic shock and the Shwartzman reaction but not endotoxin tolerance. J Clin Invest. 1995;96(5):2339-47.
56. Jiang HR, Muckersie E, Robertson M, Xu H, Liversidge J, Forrester JV. Secretion of interleukin-10 or interleukin-12 by LPS-activated dendritic cells is critically dependent on time of stimulus relative to initiation of purified DC culture. J Leukoc Biol. 2002;72(5):978-85. (Pubitemid 35365172)
57. Bedford PA, Todorovic V, Westcott ED, Windsor AC, English NR, Al-Hassi HO, Raju KS, Mills S, Knight SC. Adipose tissue of human omentum is a major source of dendritic cells, which lose MHC Class II and stimulatory function in Crohn's disease. J Leukoc Biol. 2006;80(3):546-54. (Pubitemid 44835788)
58. Peng W, Gao T, Yang ZL, Zhang SC, Ren ML, Wang ZG, Zhang B. Adipose-derived stem cells induced dendritic cells undergo tolerance and inhibit Th1 polarization. Cell Immunol. 2012;278(1-2):152-7.
59. Bala M, Kopp A, Wurm S, Büchler C, Schölmerich J, Schäffler A. Type 2 diabetes and lipoprotein metabolism affect LPS-induced cytokine and chemokine release in primary human monocytes. Exp Clin Endocrinol Diabetes. 2011;119(6):370-6.
60. Litwin M, Michałkiewicz J, Niemirska A, Gackowska L, Kubiszewska I, Wierzbicka A, Wawer ZT, Janas R. Inflammatory activation in children with primary hypertension. Pediatr Nephrol. Pediatr Nephrol. 2010;25(9):1711-8 Epub 2010 May 21. Erratum in: Pediatr Nephrol. 2010;25(12):2549.
61. Poulos SP, Dodson MV, Hausman GJ. Cell line models for differentiation: pre-adipocytes and adipocytes. Exp Biol Med (Maywood). 2010;235(10):1185-93.
62. Trellakis S, Rydleuskaya A, Fischer C, Canbay A, Tagay S, Scherag A, Bruderek K, Schuler PJ, Brandau S. Low adiponectin, high levels of apoptosis and increased peripheral blood neutrophil activity in healthy obese subjects. Obes Facts. 2012;5(3):305-18.
63. Loughrey BV, McGinty A, Young IS, McCance DR, Powell LA. Increased circulating CC chemokine levels in the metabolic syndrome are reduced by low-dose atorvastatin treatment: evidence from a randomized controlled trial. Clin Endocrinol (Oxf). 2013;79:800-6.
64. Ognjanovic S, Jacobs DR, Steinberger J, Moran A, Sinaiko AR. Relation of chemokines to BMI and insulin resistance at ages 18-21. Int J Obes (Lond). 2013;37(3):420-3.
65. Błogowski W, Budkowska M, Sałata D, Serwin K, Dołȩgowska B, Łokaj M, Prowans P, Starzyńska T. Clinical analysis of selected complement-derived molecules in human adipose tissue. J Transl Med. 2013;11:11.